CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Thalys Medical Technology Group Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Thalys Medical Technology Group Corp
No.1310 Jinshan Avenue
Dongxi Lake District
Phone: +86 2783386020p:+86 2783386020 WUHAN, HUB  430040  China Ticker: 603716603716
Business Summary
Thalys Medical Technology Group Corp is a China-based company primarily engaged in the provision of integrated medical service operation services. The Company mainly operates three businesses. The pure sales business is engaged in the sale of the Company's products. The integrated in vitro diagnostics (IVD) business is engaged in the research, development, production and management of IVD reagents and instruments. The IVD products mainly include fully automated immunofluorescence analyzers, Thalys brand coagulation reagents, fully automated immunoblotting instruments, flow cytometry reagents, Myrna instruments and TriVerity reagent kits. The integrated supply, processing and distribution (SPD) business is engaged in the provision of medical institutions with centralized procurement and settlement of medical consumables, in-hospital medical supply warehousing management and distribution, and data analysis services through its self-developed SPD business operation software system.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
3845 Electromedical and electrotherapeutic apparatus
4225 General warehousing and storage
5047 Medical, dental, and hospital equipment and supplies
8742 Management consulting services
7373 Computer integrated systems design
7372 Prepackaged software

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board WeiWen 55 8/12/2024 7/1/2015
Chief Financial Officer YanShen 47 1/20/2023 1/20/2023
General Manager, Director ZhengWang 57 8/12/2024 8/12/2024
10 additional Officers and Directors records available in full report.

Business Names
Business Name
603716
Beijing Jingyang Tonewall Technology Development

General Information
Number of Employees: 1,246 (As of 12/31/2024)
Outstanding Shares: 210,199,126 (As of 1/20/2026)
Shareholders: 30,565
Stock Exchange: SHA
Fax Number: +86 2783386020


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, February 3, 2026